Phio Pharmaceuticals (PHIO) EPS (Basic) (2016 - 2020)
Historic EPS (Basic) for Phio Pharmaceuticals (PHIO) over the last 9 years, with Q4 2020 value amounting to -$0.41.
- Phio Pharmaceuticals' EPS (Basic) rose 9292.13% to -$0.41 in Q4 2020 from the same period last year, while for Sep 2021 it was -$0.18, marking a year-over-year increase of 8831.69%. This contributed to the annual value of -$10.1 for FY2022, which is 1874.5% up from last year.
- As of Q4 2020, Phio Pharmaceuticals' EPS (Basic) stood at -$0.41, which was up 9292.13% from -$0.4 recorded in Q3 2020.
- In the past 5 years, Phio Pharmaceuticals' EPS (Basic) ranged from a high of -$0.34 in Q2 2020 and a low of -$13.48 during Q4 2018
- Over the past 5 years, Phio Pharmaceuticals' median EPS (Basic) value was -$1.99 (recorded in 2017), while the average stood at -$3.04.
- In the last 5 years, Phio Pharmaceuticals' EPS (Basic) crashed by 142057.07% in 2018 and then soared by 9292.13% in 2020.
- Quarter analysis of 5 years shows Phio Pharmaceuticals' EPS (Basic) stood at -$6.54 in 2016, then soared by 86.45% to -$0.89 in 2017, then crashed by 1420.57% to -$13.48 in 2018, then surged by 57.04% to -$5.79 in 2019, then skyrocketed by 92.92% to -$0.41 in 2020.
- Its EPS (Basic) was -$0.41 in Q4 2020, compared to -$0.4 in Q3 2020 and -$0.34 in Q2 2020.